These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 35865090)

  • 1. Target-based anticancer indole derivatives and insight into structure‒activity relationship: A mechanistic review update (2018-2021).
    Dhiman A; Sharma R; Singh RK
    Acta Pharm Sin B; 2022 Jul; 12(7):3006-3027. PubMed ID: 35865090
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Indole Antitumor Agents in Nanotechnology Formulations: An Overview.
    Russo E; Grondona C; Brullo C; Spallarossa A; Villa C; Tasso B
    Pharmaceutics; 2023 Jun; 15(7):. PubMed ID: 37514002
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent Development in Indole Derivatives as Anticancer Agents for Breast Cancer.
    Kaur K; Jaitak V
    Anticancer Agents Med Chem; 2019; 19(8):962-983. PubMed ID: 30864529
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and Preclinical Evaluation of Indole Triazole Conjugates as Microtubule Targeting Agents that are Effective against MCF-7 Breast Cancer Cell Lines.
    Yele V; Pindiprolu SKSS; Sana S; Ramamurty DSVNM; Madasi JRK; Vadlamani S
    Anticancer Agents Med Chem; 2021; 21(8):1047-1055. PubMed ID: 32981511
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent Development in Indole Derivatives as Anticancer Agent: A Mechanistic Approach.
    Devi N; Kaur K; Biharee A; Jaitak V
    Anticancer Agents Med Chem; 2021; 21(14):1802-1824. PubMed ID: 33397272
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Medicinal chemistry of indole derivatives: Current to future therapeutic prospectives.
    Kumari A; Singh RK
    Bioorg Chem; 2019 Aug; 89():103021. PubMed ID: 31176854
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design, synthesis, in vitro antiproliferative activity and apoptosis-inducing studies of 1-(3',4',5'-trimethoxyphenyl)-3-(2'-alkoxycarbonylindolyl)-2-propen-1-one derivatives obtained by a molecular hybridisation approach.
    Preti D; Romagnoli R; Rondanin R; Cacciari B; Hamel E; Balzarini J; Liekens S; Schols D; Estévez-Sarmiento F; Quintana J; Estévez F
    J Enzyme Inhib Med Chem; 2018 Dec; 33(1):1225-1238. PubMed ID: 30141353
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent Developments in the Synthesis and Anticancer Activity of Indole and Its Derivatives.
    Kaur B; Venugopal S; Verma A; Sahu SK; Wadhwa P; Kumar D; Sharma A
    Curr Org Synth; 2023; 20(4):376-394. PubMed ID: 35538803
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Indole molecules as inhibitors of tubulin polymerization: potential new anticancer agents, an update (2013-2015).
    Patil R; Patil SA; Beaman KD; Patil SA
    Future Med Chem; 2016 Jul; 8(11):1291-316. PubMed ID: 27476704
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Medicinal Chemist's Perspective Towards Structure Activity Relationship of Heterocycle Based Anticancer Agents.
    Nehra B; Mathew B; Chawla PA
    Curr Top Med Chem; 2022; 22(6):493-528. PubMed ID: 35021975
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Indole derivatives as tubulin polymerization inhibitors for the development of promising anticancer agents.
    Hong Y; Zhu YY; He Q; Gu SX
    Bioorg Med Chem; 2022 Feb; 55():116597. PubMed ID: 34995858
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Indole derivatives (2010-2020) as versatile tubulin inhibitors: synthesis and structure-activity relationships.
    Naaz F; Neha K; Haider MR; Shafi S
    Future Med Chem; 2021 Oct; 13(20):1795-1828. PubMed ID: 34468201
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent Developments in Oxazole Derivatives as Anticancer Agents: Review on Synthetic Strategies, Mechanism of Action and SAR Studies.
    Kulkarni S; Kaur K; Jaitak V
    Anticancer Agents Med Chem; 2022; 22(10):1859-1882. PubMed ID: 34525925
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Indole Derivatives as Anticancer Agents for Breast Cancer Therapy: A Review.
    Sidhu JS; Singla R; Mayank ; Jaitak V
    Anticancer Agents Med Chem; 2015; 16(2):160-73. PubMed ID: 25991424
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Indole: A promising scaffold for the discovery and development of potential anti-tubercular agents.
    Bajad NG; Singh SK; Singh SK; Singh TD; Singh M
    Curr Res Pharmacol Drug Discov; 2022; 3():100119. PubMed ID: 35992375
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Moxifloxacin-isatin Hybrids Tethered by 1,2,3-triazole and their Anticancer Activities.
    Yang M; Liu H; Zhang Y; Wang X; Xu Z
    Curr Top Med Chem; 2020; 20(16):1461-1467. PubMed ID: 31994464
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Indole Derivatives as Anti-Tubercular Agents: An Overview on their Synthesis and Biological Activities.
    Reddy GS; Pal M
    Curr Med Chem; 2021; 28(22):4531-4568. PubMed ID: 32951569
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Benzimidazole and its derivatives as cancer therapeutics: The potential role from traditional to precision medicine.
    Lee YT; Tan YJ; Oon CE
    Acta Pharm Sin B; 2023 Feb; 13(2):478-497. PubMed ID: 36873180
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Medicinal Perspective of Indole Derivatives: Recent Developments and Structure-Activity Relationship Studies.
    Kumar D; Sharma S; Kalra S; Singh G; Monga V; Kumar B
    Curr Drug Targets; 2020; 21(9):864-891. PubMed ID: 32156235
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Indole in the target-based design of anticancer agents: A versatile scaffold with diverse mechanisms.
    Dadashpour S; Emami S
    Eur J Med Chem; 2018 Apr; 150():9-29. PubMed ID: 29505935
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.